| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.0067 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.00084 | 1 |